19-53801228-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_144687.4(NLRP12):​c.2755C>T​(p.Arg919Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,613,682 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R919Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0065 ( 17 hom., cov: 30)
Exomes 𝑓: 0.00074 ( 12 hom. )

Consequence

NLRP12
NM_144687.4 missense, splice_region

Scores

1
4
12
Splicing: ADA: 0.00003798
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0430

Publications

6 publications found
Variant links:
Genes affected
NLRP12 (HGNC:22938): (NLR family pyrin domain containing 12) This gene encodes a member of the CATERPILLER family of cytoplasmic proteins. The encoded protein, which contains an N-terminal pyrin domain, a NACHT domain, a NACHT-associated domain, and a C-terminus leucine-rich repeat region, functions as an attenuating factor of inflammation by suppressing inflammatory responses in activated monocytes. Mutations in this gene cause familial cold autoinflammatory syndrome type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
NLRP12 Gene-Disease associations (from GenCC):
  • familial cold autoinflammatory syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013561815).
BP6
Variant 19-53801228-G-A is Benign according to our data. Variant chr19-53801228-G-A is described in ClinVar as Benign. ClinVar VariationId is 330010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00649 (987/152032) while in subpopulation AFR AF = 0.0219 (908/41494). AF 95% confidence interval is 0.0207. There are 17 homozygotes in GnomAd4. There are 486 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 987 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP12NM_144687.4 linkc.2755C>T p.Arg919Trp missense_variant, splice_region_variant Exon 7 of 10 ENST00000324134.11 NP_653288.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP12ENST00000324134.11 linkc.2755C>T p.Arg919Trp missense_variant, splice_region_variant Exon 7 of 10 1 NM_144687.4 ENSP00000319377.6
NLRP12ENST00000345770.9 linkc.2758C>T p.Arg920Trp missense_variant, splice_region_variant Exon 7 of 9 1 ENSP00000341428.5
NLRP12ENST00000391772.1 linkc.2591+2721C>T intron_variant Intron 6 of 6 1 ENSP00000375652.1

Frequencies

GnomAD3 genomes
AF:
0.00648
AC:
985
AN:
151914
Hom.:
18
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0219
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00303
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00624
GnomAD2 exomes
AF:
0.00172
AC:
430
AN:
250276
AF XY:
0.00117
show subpopulations
Gnomad AFR exome
AF:
0.0234
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000142
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000738
AC:
1079
AN:
1461650
Hom.:
12
Cov.:
35
AF XY:
0.000634
AC XY:
461
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.0233
AC:
779
AN:
33472
American (AMR)
AF:
0.00103
AC:
46
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5762
European-Non Finnish (NFE)
AF:
0.000169
AC:
188
AN:
1111824
Other (OTH)
AF:
0.00103
AC:
62
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00649
AC:
987
AN:
152032
Hom.:
17
Cov.:
30
AF XY:
0.00654
AC XY:
486
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.0219
AC:
908
AN:
41494
American (AMR)
AF:
0.00302
AC:
46
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
67980
Other (OTH)
AF:
0.00618
AC:
13
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
2
Bravo
AF:
0.00713
ESP6500AA
AF:
0.0216
AC:
95
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00210
AC:
255
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial cold autoinflammatory syndrome 2 Benign:5
Oct 21, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 21, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 15, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NLRP12: BP4, BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autoinflammatory syndrome Benign:1
Mar 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T;.;.;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.75
FATHMM_MKL
Benign
0.083
N
LIST_S2
Benign
0.67
T;T;T;T
MetaRNN
Benign
0.0089
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.5
L;L;.;.
PhyloP100
-0.043
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.5
D;N;N;D
REVEL
Benign
0.18
Sift
Benign
0.076
T;T;T;T
Sift4G
Uncertain
0.017
D;T;D;T
Vest4
0.40
ClinPred
0.028
T
GERP RS
-0.83
Varity_R
0.12
gMVP
0.57
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000038
dbscSNV1_RF
Benign
0.040
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61741349; hg19: chr19-54304482; API